Thank you to all who were able to join our webinar on April 21, 2026.

On April 21, 2026, Toxicogenomica presented a webinar on inherited mutations that cause mesotheliomas and other cancers, independent of asbestos or other toxicants. The webinar covered important recent updates on new rulings on the use of genomic evidence in personal injury cases, and a discussion of new scientific studies from 2025 and early 2026.
Download your copy of the presentation by completing the form below.

Speakers:

• Len van Zyl, Ph.D., CEO, ArrayXpress Inc., Raleigh, NC
• Kirk Hartley, Principal, LSP Group LLC, Chicago, IL 
• Giovanni Ciavarra, Principal, Lumanity, New York

Topics that were discussed:

• Genomic Science and Law Issues Expected in 2026
• Update on Rulings on Genomic Evidence in Personal Injury Cases
• Comments on Key Scientific Studies from 2025

ABOUT US

ToxicoGenomica is a multidisciplinary group of scientists and lawyers whose mission is to provide fully integrated services for using genomics and systems biology data in civil litigation. Members of the ToxicoGenomica team have been involved in delivering this type of information in toxic tort cases and are dedicated to accelerating the dissemination of information about the applications of genomics and systems biology to issues involving disease causation.